Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 225

1.

Imputation of canine genotype array data using 365 whole-genome sequences improves power of genome-wide association studies.

Hayward JJ, White ME, Boyle M, Shannon LM, Casal ML, Castelhano MG, Center SA, Meyers-Wallen VN, Simpson KW, Sutter NB, Todhunter RJ, Boyko AR.

PLoS Genet. 2019 Sep 16;15(9):e1008003. doi: 10.1371/journal.pgen.1008003. [Epub ahead of print]

PMID:
31525180
2.

Conformational transitions in the active site of mycobacterial 2-oxoglutarate dehydrogenase upon binding phosphonate analogues of 2-oxoglutarate: From a Michaelis-like complex to ThDP adducts.

Wagner T, Boyko A, Alzari PM, Bunik VI, Bellinzoni M.

J Struct Biol. 2019 Aug 30. pii: S1047-8477(19)30182-0. doi: 10.1016/j.jsb.2019.08.012. [Epub ahead of print]

PMID:
31476368
3.

[Genetic Markers for Personalized Therapy of Polygenic Diseases: Pharmacogenetics of Multiple Sclerosis].

Tsareva EY, Favorova OO, Boyko AN, Kulakova OG.

Mol Biol (Mosk). 2019 Jul-Aug;53(4):574-599. doi: 10.1134/S0026898419040153. Russian.

4.

Determination of S-adenosylmethionine and S-adenosylhomocysteine in blood plasma by UPLC with fluorescence detection.

Ivanov AV, Dubchenko EA, Kruglova MP, Virus ED, Bulgakova PO, Alexandrin VV, Fedoseev AN, Boyko AN, Grachev SV, Kubatiev AA.

J Chromatogr B Analyt Technol Biomed Life Sci. 2019 Aug 15;1124:366-374. doi: 10.1016/j.jchromb.2019.06.032. Epub 2019 Jun 27.

PMID:
31295723
5.

Molecular Surveillance of HIV-1 infection in Krasnoyarsk Region, Russia: Epidemiology, Phylodynamics and Phylogeography.

Neshumaev D, Lebedev A, Malysheva M, Boyko A, Skudarnov S, Ozhmegova E, Antonova A, Kazennova E, Bobkova M.

Curr HIV Res. 2019 Jun 18. doi: 10.2174/1570162X17666190618155816. [Epub ahead of print]

PMID:
31210113
6.

Loading Rate of Exogenous and Autoantigenic Determinants on Major Histocompatibility Complex Class II Mediates Resistance to Multiple Sclerosis.

Mamedov AE, Zakharova MY, Favorova OO, Kulakova OG, Boyko AN, Knorre VD, Vorobieva NA, Khurs EN, Kiselev IS, Baulina NM, Gabibov AG, Belogurov AA.

Dokl Biochem Biophys. 2019 Mar;485(1):115-118. doi: 10.1134/S1607672919020078. Epub 2019 Jun 14.

PMID:
31201628
7.

[Cancers and multiple sclerosis: risk of comorbidity and influence of disease modifying therapy].

Boyko AN.

Zh Nevrol Psikhiatr Im S S Korsakova. 2019;119(2. Vyp. 2):86-93. doi: 10.17116/jnevro20191192286. Russian.

PMID:
31156246
8.

[Efficacy, tolerability and safety of the treatment with teberif: the results of a 2-year randomized clinical trial of treatment naïve patients with remitting multiple sclerosis, who have not received DMT, after switching from other interferon β-1a].

Boyko AN, Bosenko LP, Vasilovskiy VV, Volkova LI, Zakharova MN, Kotov SV, Lekomtseva EV, Negrich TI, Parshina EV, Patrusheva OP, Prokopenko SV, Sazonov DV, Timchenko LV, Trinitatskiy YV, Khabirov FA, Khavunka MY, Chichanovskaya LV, Sherman MA, Ivanov RA, Lin'kova YN, Stukalina EY, Zinkina-Orikhan AV, Obukhova IG.

Zh Nevrol Psikhiatr Im S S Korsakova. 2019;119(2. Vyp. 2):73-85. doi: 10.17116/jnevro20191192273. Russian.

PMID:
31156245
9.

[Serotonergic system as a therapeutic target in multiple sclerosis].

Sviridova AA, Melnikov MV, Belousova OO, Rogovskii VS, Pashenkov MV, Boyko AN.

Zh Nevrol Psikhiatr Im S S Korsakova. 2019;119(2. Vyp. 2):64-72. doi: 10.17116/jnevro20191192264. Russian.

PMID:
31156244
10.

[Anxiety and depressive psychopathological characteristics of patients with multiple sclerosis at different stages of disease].

Malygin VL, Boyko AN, Konovalova OE, Pahtusova EE, Dumbrova EV, Tishina IA, Malygin YV.

Zh Nevrol Psikhiatr Im S S Korsakova. 2019;119(2. Vyp. 2):58-63. doi: 10.17116/jnevro20191192258. Russian.

PMID:
31156243
11.

[Influence of psychopathological factors and personality traits on the results of the study of quality of life in patients with multiple sclerosis].

Malygin VL, Boyko AN, Konovalova OE, Iskandirova AS, Dumbrova EV, Boyko OV, Malygin YV.

Zh Nevrol Psikhiatr Im S S Korsakova. 2019;119(2. Vyp. 2):42-48. doi: 10.17116/jnevro20191192242. Russian.

PMID:
31156240
12.

[Clinical-epidemiological characteristics of multiple sclerosis and neuroopticomyelitis in the Central Asia].

Khaibullin TN, Kirillova EV, Bikbaev RM, Boyko AN.

Zh Nevrol Psikhiatr Im S S Korsakova. 2019;119(2. Vyp. 2):12-17. doi: 10.17116/jnevro20191192212. Russian.

PMID:
31156235
13.

Higher satisfaction and adherence with glatiramer acetate 40 mg/mL TIW vs 20 mg/mL QD in RRMS.

Cutter G, Veneziano A, Grinspan A, Al-Banna M, Boyko A, Zakharova M, Maida E, Pasic MB, Gandhi SK, Everts R, Cordioli C, Rossi S.

Mult Scler Relat Disord. 2019 Aug;33:13-21. doi: 10.1016/j.msard.2019.04.036. Epub 2019 May 9.

14.

Inbreeding depression causes reduced fecundity in Golden Retrievers.

Chu ET, Simpson MJ, Diehl K, Page RL, Sams AJ, Boyko AR.

Mamm Genome. 2019 Jun;30(5-6):166-172. doi: 10.1007/s00335-019-09805-4. Epub 2019 May 21.

15.

[Variability of the MIR196A2 Gene as a Risk Factor in Primary-Progressive Multiple Sclerosis Development].

Kiselev IS, Kulakova OG, Baulina NM, Bashinskaya VV, Popova EV, Boyko AN, Favorova OO.

Mol Biol (Mosk). 2019 Mar-Apr;53(2):282-289. doi: 10.1134/S0026898419020071. Russian.

16.

Simple nutrients bypass the requirement for HLH-30 in coupling lysosomal nutrient sensing to survival.

Murphy JT, Liu H, Ma X, Shaver A, Egan BM, Oh C, Boyko A, Mazer T, Ang S, Khopkar R, Javaheri A, Kumar S, Jiang X, Ory D, Mani K, Matkovich SJ, Kornfeld K, Diwan A.

PLoS Biol. 2019 May 14;17(5):e3000245. doi: 10.1371/journal.pbio.3000245. eCollection 2019 May.

17.

A novel variant m.641A>T in the mitochondrial MT-TF gene is associated with epileptic encephalopathy in adolescent.

Itkis Y, Krylova T, Pechatnikova NL, De Grassi A, Tabakov VY, Pierri CL, Aleshin V, Boyko A, Bunik VI, Zakharova EY.

Mitochondrion. 2019 Jul;47:10-17. doi: 10.1016/j.mito.2019.04.004. Epub 2019 Apr 19.

PMID:
31009750
18.

Cellular energetics and mitochondrial uncoupling in canine aging.

Nicholatos JW, Robinette TM, Tata SVP, Yordy JD, Francisco AB, Platov M, Yeh TK, Ilkayeva OR, Huynh FK, Dokukin M, Volkov D, Weinstein MA, Boyko AR, Miller RA, Sokolov I, Hirschey MD, Libert S.

Geroscience. 2019 Apr;41(2):229-242. doi: 10.1007/s11357-019-00062-6. Epub 2019 Apr 1.

19.

Non-viral Delivery of Zinc Finger Nuclease mRNA Enables Highly Efficient In Vivo Genome Editing of Multiple Therapeutic Gene Targets.

Conway A, Mendel M, Kim K, McGovern K, Boyko A, Zhang L, Miller JC, DeKelver RC, Paschon DE, Mui BL, Lin PJC, Tam YK, Barbosa C, Redelmeier T, Holmes MC, Lee G.

Mol Ther. 2019 Apr 10;27(4):866-877. doi: 10.1016/j.ymthe.2019.03.003. Epub 2019 Mar 7.

PMID:
30902585
20.

MiRNAs from DLK1-DIO3 Imprinted Locus at 14q32 are Associated with Multiple Sclerosis: Gender-Specific Expression and Regulation of Receptor Tyrosine Kinases Signaling.

Baulina N, Osmak G, Kiselev I, Popova E, Boyko A, Kulakova O, Favorova O.

Cells. 2019 Feb 8;8(2). pii: E133. doi: 10.3390/cells8020133.

21.

Reference assembly and gene expression analysis of Apostichopus japonicus larval development.

Boyko AV, Girich AS, Eliseikina MG, Maslennikov SI, Dolmatov IY.

Sci Rep. 2019 Feb 4;9(1):1131. doi: 10.1038/s41598-018-37755-5.

22.

Variants of Mitochondrial Genome and Risk of Multiple Sclerosis Development in Russians.

Kozin MS, Kulakova OG, Kiselev IS, Balanovsky OP, Boyko AN, Favorova OO.

Acta Naturae. 2018 Oct-Dec;10(4):79-86.

23.

Genetic differences between primary progressive and relapsing-remitting multiple sclerosis: The impact of immune-related genes variability.

Kiselev I, Bashinskaya V, Baulina N, Kozin M, Popova E, Boyko A, Favorova O, Kulakova O.

Mult Scler Relat Disord. 2019 Apr;29:130-136. doi: 10.1016/j.msard.2019.01.033. Epub 2019 Jan 24.

PMID:
30711878
24.

The effects of Z56822977 on biosynthesis of serotonin in the brain of rats in the conditions of MSG-induced obesity.

Konopelniuk V, Falalyeyeva T, Tsyryuk O, Savchenko Y, Kobyliak N, Prybytko I, Kovalchuk O, Boyko A, Arkhipov VV, Moroz Y, Ostapchenko L.

Endokrynol Pol. 2018;69(5):536-544. doi: 10.5603/EP.2018.0058.

25.
26.

International consensus on quality standards for brain health-focused care in multiple sclerosis.

Hobart J, Bowen A, Pepper G, Crofts H, Eberhard L, Berger T, Boyko A, Boz C, Butzkueven H, Celius EG, Drulovic J, Flores J, Horáková D, Lebrun-Frénay C, Marrie RA, Overell J, Piehl F, Rasmussen PV, Sá MJ, Sîrbu CA, Skromne E, Torkildsen Ø, van Pesch V, Vollmer T, Zakaria M, Ziemssen T, Giovannoni G.

Mult Scler. 2018 Nov 1:1352458518809326. doi: 10.1177/1352458518809326. [Epub ahead of print]

PMID:
30381987
27.

Direct-to-consumer DNA testing of 6,000 dogs reveals 98.6-kb duplication associated with blue eyes and heterochromia in Siberian Huskies.

Deane-Coe PE, Chu ET, Slavney A, Boyko AR, Sams AJ.

PLoS Genet. 2018 Oct 4;14(10):e1007648. doi: 10.1371/journal.pgen.1007648. eCollection 2018 Oct.

28.

Antimicrobial action of calprotectin that does not involve metal withholding.

Besold AN, Culbertson EM, Nam L, Hobbs RP, Boyko A, Maxwell CN, Chazin WJ, Marques AR, Culotta VC.

Metallomics. 2018 Dec 12;10(12):1728-1742. doi: 10.1039/c8mt00133b.

PMID:
30206620
29.

[Issues of the current terminology in multiple sclerosis].

Boyko AN, Guseva MR, Khachanova NV, Gusev EI.

Zh Nevrol Psikhiatr Im S S Korsakova. 2018;118(8. Vyp. 2):121-127. doi: 10.17116/jnevro2018118082121. Russian.

PMID:
30160680
30.

[Additional possible mechanisms of the action of ocrelizumab in multiple sclerosis on example of a case-report].

Boyko OV, Khoroshylova II, Petrov SV, Lush NY, Guseva ME, Boyko AN.

Zh Nevrol Psikhiatr Im S S Korsakova. 2018;118(8. Vyp. 2):116-120. doi: 10.17116/jnevro2018118082116. Russian.

PMID:
30160679
31.

[The risk of ischemic stroke in patients with multiple sclerosis].

Sivertseva SA, Prilenskaya AM, Sivertsev MY, Bazhukhin DV, Smirnova NF, Guseva ME, Boyko AN.

Zh Nevrol Psikhiatr Im S S Korsakova. 2018;118(8. Vyp. 2):88-94. doi: 10.17116/jnevro201811808288. Review. Russian.

PMID:
30160674
32.

[Provision of alemtuzumab safety is one of the main components of pharmacovigilance].

Khachanova NV, Bakhtiyarova KZ, Boyko AN, Vlasov YV, Davydovskaia MV, Evdoshenko EP, Zakharova MN, Malkova NA, Sivertseva SA, Spirin NN, Stolyarov ID, Schmidt TE, Khabirov FA.

Zh Nevrol Psikhiatr Im S S Korsakova. 2018;118(8. Vyp. 2):82-87. doi: 10.17116/jnevro201811808282. Russian.

PMID:
30160673
33.

[Clinical cases of multiple sclerosis in children with cerebral palsy].

Sivertseva SA, Bykova OV, Bakhtiyarova KZ, Prilenskaya AM, Sivertsev MY, Kandala NS, Bazhukhin DV, Smirnova NF, Guseva ME, Boyko AN.

Zh Nevrol Psikhiatr Im S S Korsakova. 2018;118(8. Vyp. 2):55-61. doi: 10.17116/jnevro201811808255. Russian.

PMID:
30160669
34.

[Primary-progressive multiple sclerosis in Russia: a medical-sociological study involving patients and neurologists].

Vlasov YV, Churakov MV, Kurapov MA, Gromova TN, Popova EV, Boyko OV, Spirin NN, Sivertseva SA, Belskaya GN, Malkova NA, Habirov FA, Haybullin TI, Kotov SV, Greshnova IV, Ivashinenkova EI, Bakalova MA, Yampolskaya-Gosteva IA, Boyko AN.

Zh Nevrol Psikhiatr Im S S Korsakova. 2018;118(8. Vyp. 2):40-46. doi: 10.17116/jnevro201811808240. Russian.

PMID:
30160667
35.

[Radiologically isolated syndrome as a possible preclinical stage of primary-progressive multiple sclerosis].

Popova EV, Bryukhov VV, Boyko AN, Krotenkova MV.

Zh Nevrol Psikhiatr Im S S Korsakova. 2018;118(8. Vyp. 2):35-39. doi: 10.17116/jnevro201811808235. Russian.

PMID:
30160666
36.

[The improvement of quality of life of patients with multiple sclerosis over 15-year period].

Boyko OV, Tatarinova MY, Popova EV, Guseva MR, Boyko AN, Gusev EI.

Zh Nevrol Psikhiatr Im S S Korsakova. 2018;118(8. Vyp. 2):23-28. doi: 10.17116/jnevro201811808223. Russian.

PMID:
30160664
37.

[Anemia and dysregulation of iron metabolism in multiple sclerosis].

Belova AN, Solovieva VS, Boyko AN.

Zh Nevrol Psikhiatr Im S S Korsakova. 2018;118(8. Vyp. 2):10-17. doi: 10.17116/jnevro201811808210. Review. Russian.

PMID:
30160662
38.

Cladribine tablets' potential role as a key example of selective immune reconstitution therapy in multiple sclerosis.

Boyko AN, Boyko OV.

Degener Neurol Neuromuscul Dis. 2018 May 3;8:35-44. doi: 10.2147/DNND.S161450. eCollection 2018. Review.

39.

The evolutionary history of dogs in the Americas.

Ní Leathlobhair M, Perri AR, Irving-Pease EK, Witt KE, Linderholm A, Haile J, Lebrasseur O, Ameen C, Blick J, Boyko AR, Brace S, Cortes YN, Crockford SJ, Devault A, Dimopoulos EA, Eldridge M, Enk J, Gopalakrishnan S, Gori K, Grimes V, Guiry E, Hansen AJ, Hulme-Beaman A, Johnson J, Kitchen A, Kasparov AK, Kwon YM, Nikolskiy PA, Lope CP, Manin A, Martin T, Meyer M, Myers KN, Omura M, Rouillard JM, Pavlova EY, Sciulli P, Sinding MS, Strakova A, Ivanova VV, Widga C, Willerslev E, Pitulko VV, Barnes I, Gilbert MTP, Dobney KM, Malhi RS, Murchison EP, Larson G, Frantz LAF.

Science. 2018 Jul 6;361(6397):81-85. doi: 10.1126/science.aao4776.

PMID:
29976825
40.

Comparison of village dog and wolf genomes highlights the role of the neural crest in dog domestication.

Pendleton AL, Shen F, Taravella AM, Emery S, Veeramah KR, Boyko AR, Kidd JM.

BMC Biol. 2018 Jun 28;16(1):64. doi: 10.1186/s12915-018-0535-2.

41.

Elucidating biogeographical patterns in Australian native canids using genome wide SNPs.

Cairns KM, Shannon LM, Koler-Matznick J, Ballard JWO, Boyko AR.

PLoS One. 2018 Jun 11;13(6):e0198754. doi: 10.1371/journal.pone.0198754. eCollection 2018.

42.

Molecular mechanisms of fission in echinoderms: Transcriptome analysis.

Dolmatov IY, Afanasyev SV, Boyko AV.

PLoS One. 2018 Apr 12;13(4):e0195836. doi: 10.1371/journal.pone.0195836. eCollection 2018.

43.

Pediatric multiple sclerosis: a review.

Alroughani R, Boyko A.

BMC Neurol. 2018 Mar 9;18(1):27. doi: 10.1186/s12883-018-1026-3. Review.

44.

The influence of biogenic amines on Th17-mediated immune response in multiple sclerosis.

Melnikov M, Rogovskii V, Boyko A, Pashenkov M.

Mult Scler Relat Disord. 2018 Apr;21:19-23. doi: 10.1016/j.msard.2018.02.012. Epub 2018 Feb 12. Review.

PMID:
29454152
45.

Delayed Influence of Spinal Cord Injury on the Amino Acids of NO Metabolism in Rat Cerebral Cortex Is Attenuated by Thiamine.

Boyko A, Ksenofontov A, Ryabov S, Baratova L, Graf A, Bunik V.

Front Med (Lausanne). 2018 Jan 15;4:249. doi: 10.3389/fmed.2017.00249. eCollection 2017.

46.

[An analysis of clinical trials on the registration of similars of the original disease-modifying therapies].

Boyko AN, Zakharova MN.

Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(10. Vyp. 2):53-56. doi: 10.17116/jnevro201711710253-56. Russian.

PMID:
29359734
47.

[The search for optimal decision in the treatment of multiple sclerosis: to improve adherence not reducing the efficacy].

Popova EV, Novikova KV, Khachanova NV, Konovalova OE, Kozhieva MK, Davydovskaya MV, Boyko AN.

Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(10. Vyp. 2):48-52. doi: 10.17116/jnevro201711710248-52. Russian.

PMID:
29359733
48.

[Primary progressive multiple sclerosis: current issues of timely diagnosis].

Popova EV, Boyko AN, Barabanova MA, Antipova LN, Bakhtiyarova KZ, Belova AN, Solovieva VS, Belskaya GN, Lukashevich IG, Nikolaeva LI, Volkova LI, Turova EL, Kraeva AV, Goncharova ZA, Malkova NA, Poverennova IE, Sivertseva SA, Zhelnin AV, Trushnikova TN, Khabirov FA, Khaibullin TI.

Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(10. Vyp. 2):35-40. doi: 10.17116/jnevro201711710235-40. Review. Russian.

PMID:
29359731
49.

[Syndrome CLIPPERS (literature review and a case report)].

Sivertseva SA, Sivertsev MY, Bazhukhin DV, Vorobev DP, Boyko AN.

Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(10. Vyp. 2):24-34. doi: 10.17116/jnevro201711710224-34. Review. Russian.

PMID:
29359730
50.

[Gut human microbiota and multiple sclerosis].

Kozhieva MK, Melnikov MV, Rogovsky VS, Oleskin AV, Kabilov MR, Boyko AN.

Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(10. Vyp. 2):11-19. doi: 10.17116/jnevro201711710211-19. Russian.

PMID:
29359728

Supplemental Content

Support Center